HealthCommentary

Exploring Human Potential

Why Is Lamar Alexander (R-TN) Confused?

Mike Magee The Medical-Industrial Complex in the United States is expert at feigning cross-sector competition while quietly signaling to members that there is plenty of graft and profit in the $4 trillion (20% of GDP) for all. The net output, more evident than it ever was in the days of ’90 era “Harry and Louise” […]

Disrupter in Chief – CVS, Aetna, or Amazon?

Mike Magee In 1964, a purveyor of general merchandise based in Rhode Island, coalesced 17 locations under one entity. They were focused on market data, inventory management, and economy of scale. Within five years, they were successful enough to have 40 locations, three with in-store pharmacies. Within another decade, they had standardized their information, data, […]

The Story Behind The Pharma Savings Coupon.

Mike Magee As I’ve said before, complexity is the friend of the Medical Industrial Complex. Whether hospital, insurer, organized medicine, pharmaceutical or government agency, profitability, market advantage and career advancement can be found in the cracks of the deliberately Byzantine network. For those intent on regulating or managing the American system as it is, just […]

Substituting Robust Marketing For Scientific Evidence: Industry Pursues Legal “Free Hand” For Off-Label Promotion.

SOURCE: OFF LABEL: A FILM Mike Magee Over the past fourteen years, the pharmaceutical industry in the U.S. has successfully beaten back proposals to allow drug reimportation from Canada. These proposals were advanced by multiple members of Congress and big city mayors, and were supported by the majority of Americans. But President Bush, in negotiations […]

Calling PhRMA’s Bluff: 15 Ways To Bring US Drug Costs Under Control

Mike Magee Historically, U.S. insurers have been relatively permissive when it comes to pharmaceuticals. Most drugs were covered and reimbursed generously. That reflected two realities: drugs were a relatively small piece of the over all health care cost, and denying certain drugs coverage on formulary lists was almost always a public relations nightmare, angering both […]

Show Buttons
Hide Buttons